MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

Phase 2

Terminated

Conditions: Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified
Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified

Interventions: Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Biological: Luspatercept
Drug: Hydroxyurea
Other: Questionnaire Administration

First Posted Date: 2021-08-13

Last Posted Date: 2024-02-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 3

Registration Number: NCT05005182

Locations: 🇺🇸
Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma

Completed

Conditions: Eosinophilic Asthma

First Posted Date: 2021-08-12

Last Posted Date: 2023-03-29

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT05002621

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors

Active, not recruiting

Conditions: Anatomic Stage IB Breast Cancer AJCC v8
Prognostic Stage II Breast Cancer AJCC v8
Prognostic Stage IIA Breast Cancer AJCC v8
Prognostic Stage IIB Breast Cancer AJCC v8
Prognostic Stage IIIA Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IA Breast Cancer AJCC v8
Anatomic Stage IIIB Breast Cancer AJCC v8
Prognostic Stage IB Breast Cancer AJCC v8
Prognostic Stage III Breast Cancer AJCC v8

Interventions: Procedure: Biospecimen Collection
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2021-08-11

Last Posted Date: 2024-08-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 105

Registration Number: NCT04999826

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults

Phase 1

Completed

Conditions: Heart Failure

Interventions: Drug: Rapamune

First Posted Date: 2021-08-09

Last Posted Date: 2023-09-28

Lead Sponsor: Mayo Clinic

Target Recruit Count: 24

Registration Number: NCT04996719

Locations: 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study

Conditions: Lymphoma, Non-Hodgkin

First Posted Date: 2021-08-09

Last Posted Date: 2024-12-31

Lead Sponsor: Mayo Clinic

Target Recruit Count: 21000

Registration Number: NCT04996706

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Washington University School of Medicine in St. Louis, Saint Louis, Missouri, United States

and more 7 locations

Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation

Completed

Conditions: Sleep Disorder; Breathing-Related
Sleep Disorder; Insomnia Type
Coronary Artery Disease

First Posted Date: 2021-08-05

Last Posted Date: 2024-07-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 43

Registration Number: NCT04992676

Locations: 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

Ultrasonic Perfusion Imaging in Post-mastectomy Irradiated Patients

Not Applicable

Conditions: Breast Reconstruction
Radiation Fibrosis
Radiation Dermatitis
Fat Grafting

Interventions: Procedure: Fat grafting

First Posted Date: 2021-08-05

Last Posted Date: 2024-08-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 15

Registration Number: NCT04992650

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

A Study to Evaluate Breathing Muscle Training in Cardiac Rehab

Not Applicable

Recruiting

Conditions: Heart Failure
Healthy

Interventions: Device: Inspiratory muscle training

First Posted Date: 2021-07-30

Last Posted Date: 2024-10-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 42

Registration Number: NCT04984473

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Obinutuzumab in Primary FSGS

Phase 2

Active, not recruiting

Conditions: Primary Focal Segmental Glomerulosclerosis

Interventions: Drug: Obinutuzumab

First Posted Date: 2021-07-30

Last Posted Date: 2025-01-06

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT04983888

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Whole-Food, Plant-Based Diet for Active Crohn's Disease

Not Applicable

Withdrawn

Conditions: Crohn Disease

Interventions: Other: FODMAP Diet
Other: Whole-Food, Plant-Based Diet

First Posted Date: 2021-07-29

Last Posted Date: 2022-05-26

Lead Sponsor: Mayo Clinic

Registration Number: NCT04982666

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy